SCHEMBL13018317

SCHEMBL13018317

CCC(=O)C(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL108375 0.82
SCHEMBL6474897 0.82
SCHEMBL2882744 0.76
Hydrochloric Acid SCHEMBL28229082 0.73
Hydrochloric Acid SCHEMBL2824186 0.73
Bromide SCHEMBL23306700 0.73
Hydrochloric Acid SCHEMBL23354040 0.73
SCHEMBL22972019 0.73
SCHEMBL337741 0.71 ALDH1A1 (0.53)
Propionic Acid SCHEMBL8605319 0.69 FFAR3 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550793-B2 Spirocyclic compounds, compositions and medicinal applications thereof ADVINUS THERAPEUTICS LIMITED (IN) 2017-01-24 US disclosed
US-20150218187-A1 SPIROCYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF IMPETIS BIOSCIENCES LTD. (IN) 2015-08-06 US disclosed
US-8742167-B2 Therapeutic formulations based on asiatic acid and selected salts thereof SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2014-06-03 US disclosed
US-20100331413-A1 Therapeutic Formulations Based on Asiatic Acid and Selected Salts Thereof SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2010-12-30 US disclosed